Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence

por Greenberg, William M., Citrome, Leslie
Publicado 2015

A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40–120 mg/day) in patients with major depressive disorder

por Gommoll, Carl P., Greenberg, William M., Chen, Changzheng
Publicado 2014

Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled...

por Sambunaris, Angelo, Gommoll, Carl, Chen, Changzheng, Greenberg, William M.
Publicado 2014

Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study

por Mago, Rajnish, Forero, Giovanna, Greenberg, William M., Gommoll, Carl, Chen, Changzheng
Publicado 2013

Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study

por Mago, Rajnish, Forero, Giovanna, Greenberg, William M., Gommoll, Carl, Chen, Changzheng
Publicado 2013

Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials

por Montgomery, Stuart A., Gommoll, Carl P., Chen, Changzheng, Greenberg, William M.
Publicado 2014

Effect of renal impairment on the pharmacokinetics of levomilnacipran following a single oral dose of levomilnacipran extended-release capsule in humans

por Chen, Laishun, Greenberg, William M, Brand-Schieber, Elimor, Wangsa, Julie, Periclou, Antonia, Ghahramani, Parviz
Publicado 2015

Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder

por Freeman, Marlene P., Fava, Maurizio, Gommoll, Carl, Chen, Changzheng, Greenberg, William M., Ruth, Adam
Publicado 2016

A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder

por Sambunaris, Angelo, Bose, Anjana, Gommoll, Carl P., Chen, Changzheng, Greenberg, William M., Sheehan, David V.
Publicado 2014

Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study

por Durgam, Suresh, Greenberg, William M., Li, Dayong, Lu, Kaifeng, Laszlovszky, Istvan, Nemeth, Gyorgy, Migliore, Raffaele, Volk, Stephen
Publicado 2016